In this groundbreaking talk Ayla Annac, CEO of Invivo Sciences discusses how micro human-hearts are pioneering life saving drug discovery and diagnostics for heart diseases, cancer treatments and rare diseases. Ayla is a co-founder of InvivoSciences, Inc., which has pioneered the development of ‘human micro hearts for discovery’. Its patented 3D human cell culture and automation technologies allow pharmaceutical developers to predict individual patient response to a specific treatment accurately and to develop the cardio-safe and effective treatments.
InvivoSciences groundbreaking approach enables developers to conduct smaller sized, patient-focused clinical trials. These help to develop cardiovascular drugs more rapidly and cost-effectively, and their micro rare-disease heart model will have a significant impact on discovering the disease mechanism as well as finding a cardio-safe treatment for the life-threatening illnesses including heart failure, cancer and rare heart diseases. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx